BBI-03

N/A

Report date: 2022/05/10 11:43:45
NME

Base Information

Drug NameBBI-03
Drug Alias NameBBI03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDYRK kinase inhibitors
TargetsDYRK kinase
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVoronoi Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A